Courtney K Robinson1, Rebecca M Brotman2, Jacques Ravel3. 1. Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore. 2. Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore. Electronic address: rbrotman@som.umaryland.edu. 3. Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore. Electronic address: jravel@som.umaryland.edu.
Abstract
PURPOSE: In the past decade, remarkable relationships have been documented between dysbiosis of the human microbiota and adverse health outcomes. This review seeks to highlight some of the challenges and pitfalls that may be encountered during all stages of microbiota research, from study design and sample collection, to nucleic acid extraction and sequencing, and bioinformatic and statistical analysis. METHODS: Literature focused on human microbiota research was reviewed and summarized. RESULTS: Although most studies have focused on surveying the composition of the microbiota, fewer have explored the causal roles of these bacteria, archaea, viruses, and fungi in affecting disease states. Microbiome research is in its relatively early years and many aspects remain challenging, including the complexity and personalized aspects of microbial communities, the influence of exogenous and often confounding factors, the need to apply fundamental principles of ecology and epidemiology, the necessity for new software tools, and the rapidly evolving genomic, technological, and analytical landscapes. CONCLUSIONS: Incorporating human microbiome research in large epidemiologic studies will soon help us unravel the intricate relationships that we have with our microbial partners and provide interventional opportunities to improve human health.
PURPOSE: In the past decade, remarkable relationships have been documented between dysbiosis of the human microbiota and adverse health outcomes. This review seeks to highlight some of the challenges and pitfalls that may be encountered during all stages of microbiota research, from study design and sample collection, to nucleic acid extraction and sequencing, and bioinformatic and statistical analysis. METHODS: Literature focused on human microbiota research was reviewed and summarized. RESULTS: Although most studies have focused on surveying the composition of the microbiota, fewer have explored the causal roles of these bacteria, archaea, viruses, and fungi in affecting disease states. Microbiome research is in its relatively early years and many aspects remain challenging, including the complexity and personalized aspects of microbial communities, the influence of exogenous and often confounding factors, the need to apply fundamental principles of ecology and epidemiology, the necessity for new software tools, and the rapidly evolving genomic, technological, and analytical landscapes. CONCLUSIONS: Incorporating human microbiome research in large epidemiologic studies will soon help us unravel the intricate relationships that we have with our microbial partners and provide interventional opportunities to improve human health.
Authors: T Z DeSantis; P Hugenholtz; N Larsen; M Rojas; E L Brodie; K Keller; T Huber; D Dalevi; P Hu; G L Andersen Journal: Appl Environ Microbiol Date: 2006-07 Impact factor: 4.792
Authors: Eric A Franzosa; Xochitl C Morgan; Nicola Segata; Levi Waldron; Joshua Reyes; Ashlee M Earl; Georgia Giannoukos; Matthew R Boylan; Dawn Ciulla; Dirk Gevers; Jacques Izard; Wendy S Garrett; Andrew T Chan; Curtis Huttenhower Journal: Proc Natl Acad Sci U S A Date: 2014-05-19 Impact factor: 11.205
Authors: Larry J Forney; Pawel Gajer; Christopher J Williams; G Maria Schneider; Sara S K Koenig; Stacey L McCulle; Shara Karlebach; Rebecca M Brotman; Catherine C Davis; Kevin Ault; Jacques Ravel Journal: J Clin Microbiol Date: 2010-03-03 Impact factor: 5.948
Authors: Giovanni Bacci; Alessia Bani; Marco Bazzicalupo; Maria Teresa Ceccherini; Marco Galardini; Paolo Nannipieri; Giacomo Pietramellara; Alessio Mengoni Journal: J Genomics Date: 2015-02-01
Authors: Susan M Huse; Vincent B Young; Hilary G Morrison; Dionysios A Antonopoulos; John Kwon; Sushila Dalal; Rose Arrieta; Nathaniel A Hubert; Lici Shen; Joseph H Vineis; Jason C Koval; Mitchell L Sogin; Eugene B Chang; Laura E Raffals Journal: Microbiome Date: 2014-02-14 Impact factor: 14.650
Authors: Joshua H Gordon; Michael J LaMonte; Robert J Genco; Jiwei Zhao; Lu Li; Kathleen M Hovey; Maria Tsompana; Michael J Buck; Christopher A Andrews; Daniel I Mcskimming; Wei Zheng; Yijun Sun; Jean Wactawski-Wende Journal: High Blood Press Cardiovasc Prev Date: 2019-06-24
Authors: Chirag J Patel; Jacqueline Kerr; Duncan C Thomas; Bhramar Mukherjee; Beate Ritz; Nilanjan Chatterjee; Marta Jankowska; Juliette Madan; Margaret R Karagas; Kimberly A McAllister; Leah E Mechanic; M Daniele Fallin; Christine Ladd-Acosta; Ian A Blair; Susan L Teitelbaum; Christopher I Amos Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-07-14 Impact factor: 4.254
Authors: Carolyn D Kramer; Alexandra M Simas; Xianbao He; Robin R Ingalls; Ellen O Weinberg; Caroline Attardo Genco Journal: Anaerobe Date: 2017-04-23 Impact factor: 3.331
Authors: Rashmi Sinha; Galeb Abu-Ali; Emily Vogtmann; Anthony A Fodor; Boyu Ren; Amnon Amir; Emma Schwager; Jonathan Crabtree; Siyuan Ma; Christian C Abnet; Rob Knight; Owen White; Curtis Huttenhower Journal: Nat Biotechnol Date: 2017-10-02 Impact factor: 54.908